Podiatrists in Natchez, MS Accepting Medicare
5 Podiatrists found. Showing 1 - 5
 Dr. Richard A Myers Jr., DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 151 Jeff Davis Blvd Ste H, Natchez, MS 39120 Phone: 601-446-9850 Fax: 601-446-9833 |
 Dr. Nkechinyere Christina Nwoko, D.P.M Podiatrist - Primary Podiatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 46 Sgt Prentiss Dr Ste 201b, Natchez, MS 39120 Phone: 601-443-2465 Fax: 601-445-2000 |
 Natchez Podiatry Pllc Podiatrist - Foot Surgery Medicare: Medicare Enrolled Practice Location: 151 Jeff Davis Blvd Ste H, Natchez, MS 39120 Phone: 601-446-9850 Fax: 601-446-9833 |
Podiatry Associates Pllc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 56 Sgt Prentiss Dr, Natchez, MS 39120 Phone: 601-446-9850 Fax: 601-446-9833 |
Natchez Podiatry & Foot Surgery Pa Podiatrist - Foot Surgery Medicare: Not Enrolled in Medicare Practice Location: 228c John R Junkin Dr, Natchez, MS 39120 Phone: 601-446-9850 Fax: 601-446-9833 |
News Archive
Fatty acid entry into cells happens by diffusion
The current global epidemic of obesity-linked diabetes and its associated consequences -cardiovascular, neurological and renal diseases - is a growing public health problem for which therapeutic options are limited.
VisEn launches new imaging agent for monitoring key hypertension and renal disease biomarker
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new ReninSense680(TM) FAST imaging agent for measuring and monitoring a key hypertension and renal disease biomarker in vivo.
Medigus announces CMS' publication of fee schedules for endoscopic fundoplication procedures under CPT code 43210 effective January 2016
Medigus Ltd., a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that following the American Medical Association's (AMA) decision earlier this year to create a new Category I Current Procedural Terminology (CPT®) code for esophagogastric fundoplast...
Patent Office upholds I-Flow Corporation's patent covering infusion devices
The United States Patent and Trademark Office has once again affirmed the validity of I-Flow Corporation's patent covering the ON-Q compact collapsible infusion devices.
Janssen submits canagliflozin NDA with FDA for treatment of type 2 diabetes
Janssen Research & Development, LLC (Janssen), announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of canagliflozin, an investigational, oral, once-daily, selective sodium glucose co-transporter 2 (SGLT2) inhibitor, for the treatment of adult patients with type 2 diabetes.
› Verified 8 days ago
Physical Therapists
Speech-Language Pathologists
Occupational Therapists
Optometrists
Podiatrists
Chiropractors